Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Silicone oil migration into the orbit.

Ali Bautista S, Wladis EJ, Farber M, Falk NS, Phelps PO.

Orbit. 2018 Oct;37(5):368-370. doi: 10.1080/01676830.2017.1423345. Epub 2018 Jan 4.

PMID:
29300518
2.

Flat Electroretinography and Acute Visual Loss After Ocriplasmin Injection for Vitreomacular Adhesion Complicating Macular Schisis.

Hale BP, Au AK, Falk NS, Bhatnagar P, Beer PM.

Ophthalmic Surg Lasers Imaging Retina. 2015 Sep;46(8):888-92. doi: 10.3928/23258160-20150909-16.

PMID:
26431307
3.

DYNC2LI1 mutations broaden the clinical spectrum of dynein-2 defects.

Kessler K, Wunderlich I, Uebe S, Falk NS, Gießl A, Brandstätter JH, Popp B, Klinger P, Ekici AB, Sticht H, Dörr HG, Reis A, Roepman R, Seemanová E, Thiel CT.

Sci Rep. 2015 Jul 1;5:11649. doi: 10.1038/srep11649.

4.

Endogenous endophthalmitis with iris abscess after routine dental cleaning.

Mali JO, Falk NS, Mali YP, Mencias L.

JAMA Ophthalmol. 2015 May;133(5):616-7. doi: 10.1001/jamaophthalmol.2015.12. No abstract available.

PMID:
25719547
5.

Human papilloma virus vaccine associated uveitis.

Holt HD, Hinkle DM, Falk NS, Fraunfelder FT, Fraunfelder FW.

Curr Drug Saf. 2014 Mar;9(1):65-8.

PMID:
24191906
6.

Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy.

Wladis EJ, Falk NS, Iglesias BV, Beer PM, Gosselin EJ.

Retina. 2013 Apr;33(4):807-11. doi: 10.1097/IAE.0b013e31826d350a.

PMID:
23222459
7.

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.

Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH; Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ; Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD; Uveitis Study Group, Rose K, Haider A, Di Padova F.

Sci Transl Med. 2010 Oct 6;2(52):52ra72. doi: 10.1126/scitranslmed.3001107.

8.

Infliximab stability after reconstitution, dilution, and storage under refrigeration.

Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS.

Retina. 2010 Jan;30(1):81-4. doi: 10.1097/IAE.0b013e3181b48fb4.

PMID:
20010324
9.

Initial results of QuantiFERON-TB Gold testing in patients with uveitis.

Itty S, Bakri SJ, Pulido JS, Herman DC, Faia LJ, Tufty GT, Bennett SR, Falk NS.

Eye (Lond). 2009 Apr;23(4):904-9. doi: 10.1038/eye.2008.115. Epub 2008 May 2.

PMID:
18451874
10.

Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients.

Beer PM, Wong SJ, Hammad AM, Falk NS, O'Malley MR, Khan S.

Retina. 2006 Oct;26(8):871-6.

PMID:
17031285
11.

Role of intravitreal triamcinolone acetonide in the treatment of postoperative endophthalmitis.

Falk NS, Beer PM, Peters GB 3rd.

Retina. 2006 May-Jun;26(5):545-8.

PMID:
16770261
12.

Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.

Costello P, Bakri SJ, Beer PM, Singh RJ, Falk NS, Peters GB, Melendez JA.

Retina. 2006 Feb;26(2):191-5.

PMID:
16467677
13.

Intravitreal preservative-free triamcinolone acetonide for the treatment of macular oedema.

Bakri SJ, Shah A, Falk NS, Beer PM.

Eye (Lond). 2005 Jun;19(6):686-8.

PMID:
15332099
14.

Optometric therapy for the left brain injured patient.

Aksionoff EB, Falk NS.

J Am Optom Assoc. 1992 Aug;63(8):564-8.

PMID:
1512407
15.

The differential diagnosis of perceptual deficits in traumatic brain injury patients.

Aksionoff EB, Falk NS.

J Am Optom Assoc. 1992 Aug;63(8):554-8. Review.

PMID:
1512405
16.

The primary care optometric evaluation of the traumatic brain injury patient.

Falk NS, Aksionoff EB.

J Am Optom Assoc. 1992 Aug;63(8):547-53. Review.

PMID:
1512404

Supplemental Content

Support Center